🇺🇸 FDA
Patent

US 6162790

Inhibitors of interleukin-1.beta. converting enzyme

expired A61KA61K38/00A61P

Quick answer

US patent 6162790 (Inhibitors of interleukin-1.beta. converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/04